Of the 42 enrolled patients, 11 patients are core-binding factor AML [10 patients with RUNX1-RUNXT1/t (8;21) and 1 with CBFB/MYH11/inv (16)]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.